Rukmini Kumar, Ph.D.
Founder and Chief Scientist, Vantage Research
Rukmini Kumar obtained her Ph.D. from the University of Pittsburgh in 2004, where she developed mathematical models to understand the mechanisms of acute, systemic inflammation. She has since spent her career at the intersection of engineering and biology, as applied to drug development
Her work has contributed to scientific publications that have informed several biopharma R&D programs in diabetes, auto-immune diseases and cancer through her roles at Immunetrics & Entelos. In 2013, Rukmini co-founded Vantage Research, to provide Pharma R&D solutions that integrate biological knowledge in a quantitative manner to solve the challenging problems in novel drug discovery and development. The Vantage Modelling & Simulation team works with leading companies such as Eli Lilly, MSD, Genentech & the Gates Foundation.
Rukmini Kumar has a Bachelor’s in Physics (University of Madras), a Master’s in Physics (IIT-Madras) and a Ph.D. in Physics (University of Pittsburgh).